https://doctransparency.com/doctor/tx/austin/brian-metzger-1538306899
Medicare Enrolled

Dr. Brian Metzger, MD

Infectious Disease · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1301 W 38TH ST, Austin, TX 78705
5124599710
In practice since 2009 (17 years)
NPI: 1538306899 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Metzger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Metzger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Metzger

Dr. Brian Metzger is an infectious disease in Austin, TX, with 17 years in practice. Based on federal Medicare data, Dr. Metzger performed 595 Medicare services across 378 unique beneficiaries.

Between the years covered by Open Payments, Dr. Metzger received a total of $97,241 from 40 pharmaceutical and/or device companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Metzger is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ 595 Medicare services$ $97,241 industry payments

Medicare Practice Summary

Medicare Utilization ↗
595
Medicare services
Bottom 48% in TX for infectious disease
378
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity176$94$210
Initial hospital admission, high complexity124$134$450
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th105$25$245
Office visit, established patient (30-39 min)91$85$208
Hospital follow-up visit, moderate complexity51$64$145
Critical care, first 30-74 min48$170$450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$97,241
Total received (2018-2024)
Avg $13,892/year across 7 years
Top 6% in TX for infectious disease
40
Companies
741
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83,557 (85.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,344 (11.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,340 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,662
2023
$33,011
2022
$5,108
2021
$12,540
2020
$8,994
2019
$13,145
2018
$19,780

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ferring Pharmaceuticals Inc.
$29,923
Melinta Therapeutics, Inc.
$19,458
Cumberland Pharmaceuticals, Inc.
$16,404
Allergan Inc.
$9,250
Allergan, Inc.
$4,637
AbbVie Inc.
$3,821
Gilead Sciences, Inc.
$3,401
ViiV Healthcare Company
$2,863
Melinta Therapeutics, LLC
$1,699
Merck Sharp & Dohme Corporation
$1,104
Octapharma USA, Inc.
$511
Merck Sharp & Dohme LLC
$509
Janssen Biotech, Inc.
$485
Insmed, Inc.
$464
Astellas Pharma US Inc
$402
La Jolla Pharmaceutical Company
$326
Paratek Pharmaceuticals, Inc.
$285
Shionogi Inc
$235
ABBVIE INC.
$223
EMD Serono, Inc.
$200
Theratechnologies Inc.
$130
MAYNE PHARMA INC.
$121
PFIZER INC.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$99
Napo Pharmaceuticals Inc
$75
AIMMUNE THERAPEUTICS, INC.
$59
Theravance Biopharma, Inc.
$58
Shire North American Group Inc
$55
Vyera Pharmaceuticals, LLC
$47
ADMA BioManufacturing LLC
$42
Dynavax Technologies Corporation
$37
TETRAPHASE PHARMACEUTICALS, INC.
$36
VYERA PHARMACEUTICALS, LLC
$33
Janssen Products, LP
$30
Mayne Pharma Inc.
$28
Romark Laboratories, LC
$27
Alexion Pharmaceuticals, Inc.
$21
Smith+Nephew, Inc.
$17
Nabriva Therapeutics, plc
$13
Janssen Pharmaceuticals, Inc
$13
Top 3 companies account for 67.7% of total payments
Associated products mentioned in payments ›
ALINIA · APRETUDE · AVYCAZ · Alinia Tablets 500mg 30 count bottle · Arikayce · Baxdela · Biktarvy · CABENUVA · CRESEMBA · CUTAQUIG · CUVITRU · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DORYX · DOVATO · Daraprim · Daraprim Tablet 25mg · EGRIFTA · Fetroja · GRAFIX PL · HYQVIA · Heplisav-B · ISENTRESS · JULUCA · Juluca · Kimyrsa · LIVTENCITY · MAVYRET · Mytesi · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Orbactiv · PANZYGA · PIFELTRO · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PREVYMIS · PREZCOBIX · PREZISTA · REBYOTA · RUKOBIA · SEROSTIM · SYMTUZA · Serostim · Sivextro · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · TRUMENBA · ULTOMIRIS · VIBATIV · VOWST · Vabomere · Veklury · Vibativ · XARELTO · XERAVA · ZERBAXA · ZINPLAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for infectious disease in TX.

Equivalent to $16,343 per 100 Medicare services performed
Looking for a infectious disease in Austin?
Compare infectious diseases in the Austin area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious Diseases within 10 mi
17
Per 100K population
1.3
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Metzger is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 6%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Metzger experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Metzger performed 176 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Metzger receive payments from pharmaceutical companies?
Yes. Dr. Metzger received a total of $97,241 from 40 companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Metzger's costs compare to other infectious diseases in Austin?
Dr. Metzger's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Metzger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →